Your institution may have access to this item. Find your institution then sign in to continue.
Title
A profile of methylphenidate exposures.
Authors
Foley, R; Mrvos, R; Krenzelok, E P
Abstract
Methylphenidate is prescribed commonly for children with attention deficit hyperactivity disorder. An estimated 2.8% of US youths aged 5 to 18 years use it for the management of this disorder. Despite the widespread use of methylphenidate, the demographics and outcome of intentional and unintentional exposures to methylphenidate have not been described.